Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXXC-type zinc finger protein 5 (CXXC5) is a negative regulator of the Wnt/beta-catenin signaling pathway that functions by binding to the Dishevelled (Dvl) protein. Specifically, the C-terminal region of CXXC5 interacts with the PDZ domain of Dvl, preventing the downstream activation of Wnt signaling which is essential for stem cell differentiation and tissue regeneration (Kim et al., 2015, Nature Communications). In conditions such as androgenetic alopecia and osteoporosis, CXXC5 is often overexpressed, leading to suppressed Wnt signaling and impaired hair growth or bone formation (Lee et al., 2017, Journal of Investigative Dermatology). Therapeutic strategies focus on disrupting this protein-protein interaction (PPI) using competitive inhibitors like the PTD-DBM peptide or small molecules like KY19382. By blocking the CXXC5-Dvl interface, these agents restore Wnt/beta-catenin signaling, thereby promoting hair follicle regeneration, accelerating wound healing, and enhancing osteoblast differentiation (Kim et al., 2021, Journal of Medicinal Chemistry). This target is particularly significant in regenerative medicine as it allows for the modulation of a major signaling pathway through a specific protein interface rather than global receptor activation.
Inhibition of the protein-protein interaction (PPI) between the C-terminal domain of CXXC5 and the PDZ domain of Dishevelled (Dvl) to restore and activate the Wnt/beta-catenin signaling pathway.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CXXC-type zinc finger protein 5 (CXXC5) (CXXC5).